A practical reference on Cyclic heptapeptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Bremelanotide is a moderately large peptide with a molecular mass near 1025 daltons. In lyophilised form it appears as a white to off-white powder and is freely soluble in water and other polar solvents. The intact lactam ring is essential for receptor affinity, while linearised fragments bind far more weakly. Solutions are sensitive to extremes of pH and to prolonged exposure to light and heat, so handling typically involves buffered conditions and cold storage. Its short plasma half-life reflects rapid distribution and clearance rather than chemical breakdown inside the vial.
Development of the peptide passed through several delivery formats, including an intranasal version tested in early trials and an injectable version that entered later clinical study. Regulatory approval for a subcutaneous product in the United States was granted in 2019 after review of controlled trials in premenopausal women. Outside the clinic, the compound circulates in research and non-pharmaceutical markets under its code name, where identity and purity vary considerably between suppliers. Synonyms appearing across technical literature include bremelanotide, PT-141, and Palatin 141.
Outside the approved product, bremelanotide circulates as a research chemical sold by peptide vendors, often labelled PT-141. Such material is not manufactured under pharmaceutical quality standards, and independent testing has repeatedly found content that differs from the label. Analytical certificates supplied with a purchase are not strong evidence of purity because they are usually generated by the seller. Online discussion tends to blur the distinction between the approved drug and unregulated powder, which complicates interpretation of reported experiences.
PT-141 is the original development code for bremelanotide, a synthetic peptide first studied as a potential tanning and sexual-response agent in the 1990s. Researchers at a small American biotechnology firm designed it as a shortened analogue of melanotan II, which itself came from work on alpha-melanocyte-stimulating hormone. Early screening focused on pigmentation, but behavioural observations in animal models redirected attention toward sexual motivation. That shift made PT-141 one of the first melanocortin compounds investigated specifically for effects on desire rather than on skin colour.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Cyclic heptapeptide | Synthetic melanocortin analogue |
| Molecular formula | C50H68N14O10 | Corresponds to a mass near 1025 daltons |
| Appearance | White to off-white powder | Lyophilised solid before reconstitution |
| Solubility | Soluble in water and polar solvents | Poor solubility in nonpolar media |
| Common synonyms | Bremelanotide, PT-141 | Code name and international name used interchangeably |
Activation of MC4R in the hypothalamus is thought to influence dopaminergic signaling, which in turn affects arousal and desire. This mechanism differs from that of phosphodiesterase type 5 inhibitors, which act primarily on vascular smooth muscle in the genital region. Because the pathway is central rather than peripheral, effects are not strictly dependent on local blood flow. The precise downstream cascade linking receptor binding to behavioral outcomes remains an area of ongoing investigation.
Clinical development of bremelanotide proceeded through several reformulation attempts. An early intranasal version was discontinued, and a subcutaneous auto-injector formulation later received approval for hypoactive sexual desire disorder in premenopausal women. Approval decisions have varied by country and over time, and the product has not been universally adopted. Blood pressure elevation is a documented effect, which is why some jurisdictions require monitoring after administration. The clinical evidence base continues to evolve as additional studies are published.
Bremelanotide, developed under the code PT-141, is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone. Its structure is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, with a lactam bridge joining the aspartate and lysine side chains. The molecule has the formula C50H68N14O10 and a monoisotopic mass near 1025 daltons. It is commonly prepared as the acetate salt and appears as a white to off-white lyophilised powder in solid form. The free acid is the pharmacologically relevant species, while the counter-ion improves handling and dissolution.
Early research on PT-141 grew out of work on melanotan II, a related cyclic peptide studied for pigmentation. Investigators observed that centrally acting melanocortin agonists also influenced sexual behaviour in animal models, and the programme shifted toward that endpoint. A nasal formulation was evaluated in clinical trials but showed inconsistent absorption, and later studies used subcutaneous administration instead. Regulatory approval in the United States followed in 2019 for a defined population of premenopausal women with acquired, generalised hypoactive sexual desire disorder. That approval was specific to that group rather than a broad indication.
The peptide contains seven amino acids arranged in a ring, closed by a lactam bridge between a side-chain acid and an amine. This cyclic constraint holds the backbone in a defined conformation and increases resistance to enzymatic breakdown relative to linear analogs. N-terminal acetylation and a C-terminal amide further protect the molecule from exopeptidases. The result is a compound with a comparatively long circulation time for a small peptide. Structural modification of the bridge alters receptor affinity, which is one reason analogs in this family differ in their subtype preferences.
Whether the behavioral effect originates centrally, peripherally, or through both remains an active question. Animal experiments using receptor antagonists and site-specific injections point toward hypothalamic melanocortin circuits as a key locus, but translating those findings to humans is not straightforward. Blood pressure changes observed in trials suggest a vascular component that may be peripherally mediated. The relationship between receptor occupancy and reported effect has not been mapped in humans, and no validated biomarker predicts response. This gap makes it difficult to explain individual variability on pharmacological grounds alone.
Bremelanotide acts as an agonist at melanocortin receptors, a family of five G-protein-coupled receptors labeled MC1 through MC5. Binding studies indicate activity at several of these subtypes rather than strict selectivity for one. Signalling proceeds mainly through Gs-mediated activation of adenylyl cyclase, raising intracellular cyclic AMP. The MC4 receptor, expressed in hypothalamic and limbic circuits, is widely regarded as the subtype most relevant to sexual response. Because the molecule is not subtype-selective, effects at other melanocortin receptors are expected and are used to explain some observed side effects.
== Phytoestrogens == Most studies of phytoestrogens in soy have identified the isoflavones genistein and daidzein as its principal phytoestrogenic substances. For several soy flour samples analyzed by various persons using high-performance liquid chromatography, daidzein content ranged from 226 to 2100 micrograms per gram, and genistein content ranged from 478 to 1123 micrograms per gram. For four analyses of defatted soy meal, the concentrations were 616 and 753 micrograms per gram, respectively; for one analysis of full-fat soybean meal (whole), concentrations were 706 and 1000 micrograms per gram, respectively. On a dry-matter basis, defatting causes an increase in phytoestrogen concentration. This can be largely explained by the removal of oil mass. Although reproductive physiology of sheep is particularly sensitive to phytoestrogens, soybean meal supplementation of ewe lambs or ewes on pasture in some studies has been found to have no detrimental effect on reproductive performance.
=== Development === On July 23, 2020, the series was renewed for a third season at the aftershow hosted by Aisha Tyler for the 2020 San Diego Comic-Con@Home, less than two months before the second-season premiere. Showrunner Eric Kripke revealed that he was already working with the scripts for the season in October, hoping to have them finished and start production in early 2021 as long as the condition of the COVID-19 pandemic improved. Due to the restrictions of live-action productions during the pandemic, Kripke and the producers have the idea of keeping the fans of the series engaged while they waited for the release of the third season, leading to the anthology animated spin-off miniseries The Boys Presents: Diabolical. In January 2022, it was confirmed that the season would be getting eight episodes and that would be also following the same weekly release similarly to the previous season, with three episodes released on the premiere date and the rest being released on a weekly basis.
== Prevention == Hypervitaminosis A can be prevented by not ingesting more than the US Institute of Medicine Daily Tolerable Upper Level of intake for Vitamin A. This level is for synthetic and natural retinol ester forms of vitamin A. Carotene forms from dietary sources are not toxic. Possible pregnancy, liver disease, high alcohol consumption, and smoking are indications for close monitoring and limitation of vitamin A administration.
== Diagnosis == Definitive diagnosis is usually made at a reference laboratory with advanced biocontainment capabilities. The findings of laboratory investigation vary somewhat between the viruses but in general, there is a decrease in the total white cell count (particularly the lymphocytes), a decrease in the platelet count, an increase in the blood serum liver enzymes, and reduced blood clotting ability measured as an increase in both the prothrombin (PT) and activated partial thromboplastin times (PTT). The hematocrit may be elevated. The serum urea and creatine may be raised but this is dependent on the hydration status of the patient. The bleeding time tends to be prolonged. Labs can use RT-PCR to detect the genetic material of the virus, or an ELISA test in later stages to detect antibodies produced by the immune system.
Pakistani officials also added that they had destroyed an ammunition depot and headquarters of 205 Corps brigade headquarters in Kandahar. According to Afghan local sources, Taliban were moving tanks, military equipment, and weapons from Takhar and Badakhshan to Kabul amid the conflict with Pakistan. They further add that outposts and checkpoints in parts of northern Afghanistan had been evacuated following the redeployment of Taliban forces from these areas to border regions. UN High Commissioner for Refugees (UNHCR) state that an estimated 115,000 people in Afghanistan and around 3,000 people in Pakistan have been displaced as result of border clashes. Afghans in several cities sent pictures and messages to an Afghan media outlet saying that they were threatened and forced by Taliban to participate in demonstration against Pakistan. Some Afghans in Bamyan province said local businessmen were warned that if they did not participate in the protests, "their shops would be sealed." On 6 March, armed clashes resumed along the border between Taliban forces and Pakistani border guards. Taliban officials said that they had launched an attack on Kharlachi border crossing in Dandpatan district of Paktia province, while sharing pictures of their attack. The Taliban-led Afghan Ministry of Defense said, over the previous 24 hours, Taliban forces had attacked 28 locations in the border areas of Kandahar, Nangarhar, Kunar, Khost, Paktia, and Paktika provinces, killing 109 Pakistani soldiers and injuring 148 others.
Sources: en.wikipedia.org
== Gene and protein expression == About 20,000 protein-coding genes are expressed in human cells and nearly 70% of these genes are expressed in the normal esophagus. Some 250 of these genes are more specifically expressed in the esophagus with less than 50 genes being highly specific. The corresponding esophagus-specific proteins are mainly involved in squamous differentiation such as keratins KRT13, KRT4 and KRT6C. Other specific proteins that help lubricate the inner surface of esophagus are mucins such as MUC21 and MUC22. Many genes with elevated expression are also shared with skin and other organs that are composed of squamous epithelia.
Fragmentation of gas-phase ions is essential to tandem mass spectrometry and occurs between different stages of mass analysis. There are many methods used to fragment the ions and these can result in different types of fragmentation and thus different information about the structure and composition of the molecule.
In archaeology, the term in situ has been used variably to describe artifacts or features found undisturbed since deposition; however, its definition remains contested. Scholars distinguish between a broad usage, referring to materials recovered through controlled excavation, and a stricter usage applied only to those discovered in undisturbed depositional settings. Between these poles lies a continuum of depositional scenarios, from sealed habitation floors to slope or fluvial deposits, meaning that whether an object is in situ depends on site-specific formation processes and the degree to which stratigraphic—as well as spatial—relationships can be reconstructed. Recording the exact spatial coordinates, stratigraphic position, and surrounding matrix of depositional materials is necessary for understanding past human activities and historical processes. While artifacts are often removed for analysis, certain archaeological features—such as hearths, postholes, and architectural foundations—have to be thoroughly documented in place to preserve their contextual information during excavation. This documentation relies on various methods, including detailed field notes, scaled technical drawings, cartographic representation, and high-resolution photographic records. Current archaeological practice incorporates advanced digital technologies, including 3D laser scanning, photogrammetry, unmanned aerial vehicles, and Geographic Information Systems (GIS), to capture complex spatial relationships.
==== Compatibility and feature support ==== All DisplayPort cables are compatible with all DisplayPort devices, regardless of the version of each device or the cable certification level. All features of DisplayPort will function across any DisplayPort cable. DisplayPort does not have multiple cable designs; all DP cables have the same basic layout and wiring, and will support any feature including audio, daisy-chaining, G-Sync/FreeSync, HDR, and DSC. DisplayPort cables differ in their transmission speed support. DisplayPort specifies seven different transmission modes (RBR, HBR, HBR2, HBR3, UHBR 10, UHBR 13.5, and UHBR 20) which support progressively higher bandwidths. Not all DisplayPort cables are capable of all seven transmission modes. VESA offers certifications for various levels of bandwidth. These certifications are optional, and not all DisplayPort cables are certified by VESA. Cables with limited transmission speed are still compatible with all DisplayPort devices, but may place limits on the maximum resolution or refresh rate available. DisplayPort cables are not classified by "version". Although cables are commonly labeled with version numbers, with HBR2 cables advertised as "DisplayPort 1.2 cables" for example, this notation is not permitted by VESA. The use of version numbers with cables can falsely imply that a DisplayPort 1.4 display requires a "DisplayPort 1.4 cable", or that features introduced in version 1.4 such as HDR or DSC will not function with older "DP 1.2 cables".
Sources: en.wikipedia.org
PT-141 is a laboratory code for bremelanotide, a synthetic peptide that activates melanocortin receptors. It has been developed both as an injectable pharmaceutical product and as a research chemical. The two contexts differ sharply in how identity, purity, and dosing are controlled.
It is neither a steroid nor a naturally occurring human hormone. Bremelanotide is a manufactured peptide that mimics part of the melanocortin signalling system by binding receptor proteins. Its effects come from receptor activation, not from replacing a circulating hormone.
The internal lactam bridge locks the peptide into a defined shape, which raises receptor affinity and slows enzymatic breakdown. Linear versions of the same sequence are less stable and bind more weakly. Ring geometry is therefore central to how the molecule behaves in the body.
PT-141 is a research code for bremelanotide, a cyclic peptide that activates melanocortin receptors. It was developed for sexual dysfunction and later approved under a brand name as a subcutaneous injection. The same code is widely used by suppliers selling non-pharmaceutical material.